Comparative study of sickle cell anemia and hemoglobin SC disease: clinical characterization, laboratory biomarkers and genetic profiles.

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA (2001) 118.65

Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment. JAMA (2003) 8.18

Prophylaxis with oral penicillin in children with sickle cell anemia. A randomized trial. N Engl J Med (1986) 5.84

Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes. Blood Rev (2006) 4.46

Single-tube multiplex-PCR screen for common deletional determinants of alpha-thalassemia. Blood (2000) 3.36

Sickle cell disease in Africa: a neglected cause of early childhood mortality. Am J Prev Med (2011) 3.35

Alpha-thalassaemia. Orphanet J Rare Dis (2010) 2.40

Platelet activation in patients with sickle disease, hemolysis-associated pulmonary hypertension, and nitric oxide scavenging by cell-free hemoglobin. Blood (2007) 2.31

Predicting clinical severity in sickle cell anaemia. Br J Haematol (2005) 2.13

Vasculopathy in sickle cell disease: Biology, pathophysiology, genetics, translational medicine, and new research directions. Am J Hematol (2009) 2.05

Polymerase chain reaction amplification applied to the determination of beta-like globin gene cluster haplotypes. Am J Hematol (1989) 2.04

[Epidemiology of sickle cell disease hospital admissions in Brazil]. Rev Saude Publica (2005) 2.01

Laboratory assessment of HDL heterogeneity and function. Clin Chem (2008) 1.67

Genetic modifiers of sickle cell disease. Am J Hematol (2012) 1.66

Genetic etiologies for phenotypic diversity in sickle cell anemia. ScientificWorldJournal (2009) 1.49

Beyond the definitions of the phenotypic complications of sickle cell disease: an update on management. ScientificWorldJournal (2012) 1.40

Effect of alpha-thalassemia and beta-globin gene cluster haplotypes on the hematological and clinical features of sickle-cell anemia in Brazil. Am J Hematol (1996) 1.36

Hemoglobinopathies in newborns from Salvador, Bahia, Northeast Brazil. Cad Saude Publica (2005) 1.36

Healthcare utilization and expenditures for low income children with sickle cell disease. Pediatr Blood Cancer (2009) 1.28

Hemolysis-induced lethality involves inflammasome activation by heme. Proc Natl Acad Sci U S A (2014) 1.20

Beta s-gene-cluster haplotypes in sickle cell anemia. Clinical and hematologic features. Hematol Oncol Clin North Am (1991) 1.18

BetaS-haplotypes in sickle cell anemia patients from Salvador, Bahia, Northeastern Brazil. Braz J Med Biol Res (2003) 1.12

Platelet activation and platelet-erythrocyte aggregates in patients with sickle cell anemia. J Lab Clin Med (1997) 1.09

Fetal hemoglobin, sickling, and sickle cell disease. Adv Pediatr (1990) 1.07

Colorimetric assays for nitric oxide and nitrogen oxide species formed from nitric oxide stock solutions and donor compounds. Methods Enzymol (1996) 1.07

Clinical, hematological, and molecular characterization of sickle cell anemia pediatric patients from two different cities in Brazil. Cad Saude Publica (2005) 1.03

Biomarkers in sickle cell disease. Br J Haematol (2011) 1.01

Sickle cell disease clinical phenotypes in children from South-Western, Nigeria. Niger J Clin Pract (2014) 0.90

Arginase levels and their association with Th17-related cytokines, soluble adhesion molecules (sICAM-1 and sVCAM-1) and hemolysis markers among steady-state sickle cell anemia patients. Ann Hematol (2010) 0.87

A preliminary study of psychiatric, familial, and medical characteristics of high-utilizing sickle cell disease patients. Clin J Pain (2013) 0.86

Screening for sickle-cell disease in Brazil. Lancet (2000) 0.86

Elevated hypercoagulability markers in hemoglobin SC disease. Haematologica (2015) 0.80

Effects of nitric oxide and its congeners on sickle red blood cell deformability. Transfusion (2015) 0.78

Sickle cell anemia as a multigenetic disease: new insights into the mechanism of painful crisis. Prog Clin Biol Res (1984) 0.78

A retrospective analysis of the cost of hospitalizations for sickle cell disease with crisis in England, 2010/11. J Public Health (Oxf) (2014) 0.77

Differences in quality of life between pediatric sickle cell patients who used hydroxyurea and those who did not. Int J Health Care Qual Assur (2014) 0.77

Folate supplementation in people with sickle cell disease. Cochrane Database Syst Rev (2016) 0.77

Interaction between HBS-beta-o-thalassemia and alpha-thalassemia. Am J Med Sci (1984) 0.76

Clinical biomarkers in sickle cell disease. Saudi J Biol Sci (2014) 0.75

The reason sickle reticulocytes expose PS. Blood (2015) 0.75

Nutrient Insufficiencies/Deficiencies in Children With Sickle Cell Disease and Its Association With Increased Disease Severity. Pediatr Blood Cancer (2016) 0.75

Genetic modulation of fetal hemoglobin in hydroxyurea-treated sickle cell anemia. Am J Hematol (2017) 0.75

Association of classical markers and establishment of the dyslipidemic sub-phenotype of sickle cell anemia. Lipids Health Dis (2017) 0.75